Joe Dawson

Joe Dawson, DIRECTOR

Joe Dawson has served as a Director on Rockwell Medical's Board since November 2025.


Mr. Dawson has more than 25 years' experience in the renal care and cardiovascular markets. Throughout his career, Mr. Dawson has negotiated and secured key customer contracts, acquired companies in new product segments, and driven top- and bottom-line growth. Additionally, his mastery of FDA-regulated markets, global supply chains, and commercialization pathways for medical devices make him an invaluable addition to Rockwell Medical's board of directors as the Company seeks to grow its market share, optimize its manufacturing networks, and pursue business development opportunities.


Most recently, he was President, North America Division at Nipro Medical Corporation, a wholly owned subsidiary of Nipro Corporation. Overseeing one of the largest global medical device manufacturer's U.S. operations, Mr. Dawson's leadership included strategic P&L responsibility, operational oversight, and direct accountability for compliance in highly regulated therapeutic categories including dialysis, vascular access, and infusion technologies. Previously, he held various sales and management positions at Cordis Corporation, a Johnson & Johnson subsidiary at the time and leading developer and manufacturer of interventional vascular technology, specializing in cardiology and endovascular devices like catheters, balloons and stents. Mr. Dawson began his career at W. L. Gore & Associates, a global materials science company known for its innovative products, particularly those made from expanded polytetrafluoroethylene. Mr. Dawson earned a B.S. in Neurobiology from St. John's University.